Here, we report for the first time that 1 week of BML‐111 treatment increases CD163+ microglia/macrophage cell populations in the brain 1 week post‐stroke, indicating that BML‐111 may increase the M2c subpopulation as a mechanism of action to promote debris clearance and tissue remodeling. This evidence concerns the gene CD163 and stroke disorder.